Maypharm, a South Korean innovator in medical and dermo-cosmetic products, has launched Hyalmass Aqua-Exosome, a hybrid mesotherapy filler, to meet the evolving demands of aesthetic medicine. This product combines hyaluronic acid, exosomes and polydeoxyribonucleotide (PDRN) to address skin hydration, elasticity and regeneration: a first for aesthetic medicine.
